Capsuletech develops the SmartLinx Neuron 2 patient-monitoring and connectivity platform, where the observed vulnerability disclosures center on the firmware and system integration layers. The recurring pattern involves insufficient information in NVD filings and protection mechanism failures, reflecting the challenges of securing embedded medical device firmware and its integration into clinical workflows. Current severity, exploitation activity, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Capsuletech over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2019-5024HIGH A restricted environment escape vulnerability exists in the “kiosk mode” function of Capsule Technologies SmartLinx Neuron 2 medical information collection devices running versions | Apr 11, 2019 | 7.6 | 25 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Capsuletech.
Media articles that mention a CVE ID that affects a product developed by Capsuletech — matched by CVE ID, not by vendor name.